Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    HGB-206
Previous Study | Return to List | Next Study

A Study Evaluating the Safety and Efficacy of bb1111 in Severe Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02140554
Recruitment Status : Active, not recruiting
First Posted : May 16, 2014
Last Update Posted : June 11, 2021
Sponsor:
Information provided by (Responsible Party):
bluebird bio

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : March 2023